Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children

C. A M Morgan, Dean A Blumberg, J. D. Cherry, K. S. Reisinger, M. M. Blatter, J. L. Blumer, C. Dekker l., M. G. Stout, P. D. Christenson

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

An acellular pertussis-component Combined diphtheria and tetanus toxoids, and pertussis (APDT) vaccine adsorbed was compared with a licensed whole-cell pertussis-component combined diphtheria and tetanus toxoids, and pertussis (DTP) vaccine adsorbed for reactogenicity and immunogenicity when given as the fifth DTP immunization to eighty-two 4- to 6-year-old children. The reaction rates with both vaccines were low; APDT vaccine recipients had significantly less pain and warmth at the injection site than did DTP vaccine recipients. Antibody responses to pertussis antigens (lymphocytosis-promoting factor, filamentous hemagglutinin, anD agglutinogens) an to diphtheria and tetanus toxoids were all brisk. The APDT vaccine recipients had a more marked response in antibodies to filamentous hemagglutinin anD a less marked response in agglutinins than whole-cell vaccine recipients. On the day after immunization, both APDT and DTP vaccine recipients had an incrEase in mean leukocyte and neutrophil counts. This APDT vaccine is immunogenic and less reactogenic than a DTP vaccine with a whole-cell pertussis component when administered as a booster to 4- to 6-year-old children.

Original languageEnglish (US)
Pages (from-to)41-45
Number of pages5
JournalAmerican Journal of Diseases of Children
Volume144
Issue number1
StatePublished - 1990
Externally publishedYes

Fingerprint

Diphtheria-Tetanus-Pertussis Vaccine
Diphtheria Toxoid
Tetanus Toxoid
Whooping Cough
Cellular Structures
Double-Blind Method
Vaccines
Antibody Formation
Bordetella Virulence Factors
Immunization
Combined Vaccines
Pertussis Vaccine
Agglutinins
Hemagglutinins
Leukocyte Count
Neutrophils
Antigens
Pain
Injections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Morgan, C. A. M., Blumberg, D. A., Cherry, J. D., Reisinger, K. S., Blatter, M. M., Blumer, J. L., ... Christenson, P. D. (1990). Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children. American Journal of Diseases of Children, 144(1), 41-45.

Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children. / Morgan, C. A M; Blumberg, Dean A; Cherry, J. D.; Reisinger, K. S.; Blatter, M. M.; Blumer, J. L.; Dekker l., C.; Stout, M. G.; Christenson, P. D.

In: American Journal of Diseases of Children, Vol. 144, No. 1, 1990, p. 41-45.

Research output: Contribution to journalArticle

Morgan, CAM, Blumberg, DA, Cherry, JD, Reisinger, KS, Blatter, MM, Blumer, JL, Dekker l., C, Stout, MG & Christenson, PD 1990, 'Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children', American Journal of Diseases of Children, vol. 144, no. 1, pp. 41-45.
Morgan, C. A M ; Blumberg, Dean A ; Cherry, J. D. ; Reisinger, K. S. ; Blatter, M. M. ; Blumer, J. L. ; Dekker l., C. ; Stout, M. G. ; Christenson, P. D. / Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children. In: American Journal of Diseases of Children. 1990 ; Vol. 144, No. 1. pp. 41-45.
@article{2b4f72598115425bb0bfe5b743c1caa1,
title = "Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children",
abstract = "An acellular pertussis-component Combined diphtheria and tetanus toxoids, and pertussis (APDT) vaccine adsorbed was compared with a licensed whole-cell pertussis-component combined diphtheria and tetanus toxoids, and pertussis (DTP) vaccine adsorbed for reactogenicity and immunogenicity when given as the fifth DTP immunization to eighty-two 4- to 6-year-old children. The reaction rates with both vaccines were low; APDT vaccine recipients had significantly less pain and warmth at the injection site than did DTP vaccine recipients. Antibody responses to pertussis antigens (lymphocytosis-promoting factor, filamentous hemagglutinin, anD agglutinogens) an to diphtheria and tetanus toxoids were all brisk. The APDT vaccine recipients had a more marked response in antibodies to filamentous hemagglutinin anD a less marked response in agglutinins than whole-cell vaccine recipients. On the day after immunization, both APDT and DTP vaccine recipients had an incrEase in mean leukocyte and neutrophil counts. This APDT vaccine is immunogenic and less reactogenic than a DTP vaccine with a whole-cell pertussis component when administered as a booster to 4- to 6-year-old children.",
author = "Morgan, {C. A M} and Blumberg, {Dean A} and Cherry, {J. D.} and Reisinger, {K. S.} and Blatter, {M. M.} and Blumer, {J. L.} and {Dekker l.}, C. and Stout, {M. G.} and Christenson, {P. D.}",
year = "1990",
language = "English (US)",
volume = "144",
pages = "41--45",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children

AU - Morgan, C. A M

AU - Blumberg, Dean A

AU - Cherry, J. D.

AU - Reisinger, K. S.

AU - Blatter, M. M.

AU - Blumer, J. L.

AU - Dekker l., C.

AU - Stout, M. G.

AU - Christenson, P. D.

PY - 1990

Y1 - 1990

N2 - An acellular pertussis-component Combined diphtheria and tetanus toxoids, and pertussis (APDT) vaccine adsorbed was compared with a licensed whole-cell pertussis-component combined diphtheria and tetanus toxoids, and pertussis (DTP) vaccine adsorbed for reactogenicity and immunogenicity when given as the fifth DTP immunization to eighty-two 4- to 6-year-old children. The reaction rates with both vaccines were low; APDT vaccine recipients had significantly less pain and warmth at the injection site than did DTP vaccine recipients. Antibody responses to pertussis antigens (lymphocytosis-promoting factor, filamentous hemagglutinin, anD agglutinogens) an to diphtheria and tetanus toxoids were all brisk. The APDT vaccine recipients had a more marked response in antibodies to filamentous hemagglutinin anD a less marked response in agglutinins than whole-cell vaccine recipients. On the day after immunization, both APDT and DTP vaccine recipients had an incrEase in mean leukocyte and neutrophil counts. This APDT vaccine is immunogenic and less reactogenic than a DTP vaccine with a whole-cell pertussis component when administered as a booster to 4- to 6-year-old children.

AB - An acellular pertussis-component Combined diphtheria and tetanus toxoids, and pertussis (APDT) vaccine adsorbed was compared with a licensed whole-cell pertussis-component combined diphtheria and tetanus toxoids, and pertussis (DTP) vaccine adsorbed for reactogenicity and immunogenicity when given as the fifth DTP immunization to eighty-two 4- to 6-year-old children. The reaction rates with both vaccines were low; APDT vaccine recipients had significantly less pain and warmth at the injection site than did DTP vaccine recipients. Antibody responses to pertussis antigens (lymphocytosis-promoting factor, filamentous hemagglutinin, anD agglutinogens) an to diphtheria and tetanus toxoids were all brisk. The APDT vaccine recipients had a more marked response in antibodies to filamentous hemagglutinin anD a less marked response in agglutinins than whole-cell vaccine recipients. On the day after immunization, both APDT and DTP vaccine recipients had an incrEase in mean leukocyte and neutrophil counts. This APDT vaccine is immunogenic and less reactogenic than a DTP vaccine with a whole-cell pertussis component when administered as a booster to 4- to 6-year-old children.

UR - http://www.scopus.com/inward/record.url?scp=0025055337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025055337&partnerID=8YFLogxK

M3 - Article

C2 - 2403747

AN - SCOPUS:0025055337

VL - 144

SP - 41

EP - 45

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 1

ER -